Effect of the 2014 atrial fibrillation guideline revisions on the proportion of patients recommended for oral anticoagulation.
The Duke Clinical Research Institute, Durham, North Carolina.
Emily C
EC
O'Brien
The Duke Clinical Research Institute, Durham, North Carolina.
Sunghee
S
Kim
The Duke Clinical Research Institute, Durham, North Carolina.
Paul L
PL
Hess
Departments of Medicine and Clinical Pharmacology, Jefferson Medical College, Philadelphia, Pennsylvania.
Peter R
PR
Kowey
Division of Cardiology, University of California, Los Angeles.
Gregg C
GC
Fonarow
The Duke Clinical Research Institute, Durham, North Carolina.
Jonathan P
JP
Piccini
The Duke Clinical Research Institute, Durham, North Carolina.
Eric D
ED
Peterson
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D012042:Registries; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants